Search

everythinglearnresearchcommunity

for

Search:↓

Ginsenoside Rf from Panax ginseng promotes hair growth and could be a natural alternative for treating hair loss.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Paeoniflorin protects brain cells by involving a specific protein and neurosteroids.

Folliculin deficiency causes problems with cell division and positioning due to disrupted RhoA signaling and interaction with p0071.

Blocking EGFR in mice causes hair loss and skin changes.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Folliculotropic mycosis fungoides can occur in children and is diagnosed with specific tests, but often stays in early stages with treatment.

Gp₄G promotes hair growth and improves skin health.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

The study found a specific peptide that helps detect TGase 3 activity in skin and hair follicles.

Mealworm protein helps fat cell development and may aid in metabolic health and hair growth.

LHTric-1 is a specific antibody useful for studying hair and nail formation.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Immune system changes may contribute to female pattern hair loss.

Combining laser and corticosteroid is not better than corticosteroid alone for treating frontal fibrosing alopecia.

Type II spiral ganglion neurites avoid high concentrations of laminin and fibronectin.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

FGF18 controls hair cycle rest and growth phases.

FGFs-4, -8, and -9 have overlapping roles and are repeatedly used in tooth development.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

The study created a mouse model that survives longer and shows fewer symptoms of pemphigus vulgaris.